CD274 and inflammatory bowel disease: This groundbreaking discovery suggests that deficiency in PD-L1 signaling may promote antibiotic resistance by altering the functional profile of gut microbiota—a finding with critical implications for current antibiotic-based clinical treatment strategies for IBD.